319 related articles for article (PubMed ID: 22205151)
1. Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course.
Put N; Van Roosbroeck K; Konings P; Meeus P; Brusselmans C; Rack K; Gervais C; Nguyen-Khac F; Chapiro E; Radford-Weiss I; Struski S; Dastugue N; Gachard N; Lefebvre C; Barin C; Eclache V; Fert-Ferrer S; Laibe S; Mozziconacci MJ; Quilichini B; Poirel HA; Wlodarska I; Hagemeijer A; Moreau Y; Vandenberghe P; Michaux L;
Ann Hematol; 2012 Jun; 91(6):863-73. PubMed ID: 22205151
[TBL] [Abstract][Full Text] [Related]
2. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
[TBL] [Abstract][Full Text] [Related]
3. Discrimination of chronic lymphocytic leukemia (CLL) and CLL/PL by cytomorphology can clearly be correlated to specific genetic markers as investigated by interphase fluorescence in situ hybridization (FISH).
Bacher U; Kern W; Schoch C; Hiddemann W; Haferlach T
Ann Hematol; 2004 Jun; 83(6):349-55. PubMed ID: 15034762
[TBL] [Abstract][Full Text] [Related]
4. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation.
Nelson BP; Variakojis D; Peterson LC
Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788
[TBL] [Abstract][Full Text] [Related]
5. Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc.
Merchant S; Schlette E; Sanger W; Lai R; Medeiros LJ
Arch Pathol Lab Med; 2003 Mar; 127(3):305-9. PubMed ID: 12653573
[TBL] [Abstract][Full Text] [Related]
6. Burkitt t(8;14)(q24;q32) and cryptic deletion in a CLL patient: report of a case and review of literature.
Reddy K; Satyadev R; Bouman D; Hibbard MK; Lu G; Paolo R
Cancer Genet Cytogenet; 2006 Apr; 166(1):12-21. PubMed ID: 16616107
[TBL] [Abstract][Full Text] [Related]
7. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
[TBL] [Abstract][Full Text] [Related]
8. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
Magro CM; Morrison CD; Heerema N; Porcu P; Sroa N; Deng AC
J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
[TBL] [Abstract][Full Text] [Related]
9. B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia.
Ruchlemer R; Parry-Jones N; Brito-Babapulle V; Attolico I; Wotherspoon AC; Matutes E; Catovsky D
Br J Haematol; 2004 May; 125(3):330-6. PubMed ID: 15086413
[TBL] [Abstract][Full Text] [Related]
10. Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms.
Reindl L; Bacher U; Dicker F; Alpermann T; Kern W; Schnittger S; Haferlach T; Haferlach C
Br J Haematol; 2010 Oct; 151(1):25-36. PubMed ID: 20649559
[TBL] [Abstract][Full Text] [Related]
11. Detection of a t(4;14)(p16;q32) in two cases of lymphoma showing both the immunophenotype of chronic lymphocytic leukemia.
Bacher U; Haferlach T; Schnittger S; Weiss T; Burkhard O; Bechtel B; Kern W; Haferlach C
Cancer Genet Cytogenet; 2010 Jul; 200(2):170-4. PubMed ID: 20620602
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis.
Cavazzini F; Hernandez JA; Gozzetti A; Russo Rossi A; De Angeli C; Tiseo R; Bardi A; Tammiso E; Crupi R; Lenoci MP; Forconi F; Lauria F; Marasca R; Maffei R; Torelli G; Gonzalez M; Martin-Jimenez P; Maria Hernandez J; Rigolin GM; Cuneo A
Br J Haematol; 2008 Aug; 142(4):529-37. PubMed ID: 18547320
[TBL] [Abstract][Full Text] [Related]
13. Burkitt-like mutations in the c-myc gene locus in prolymphocytic leukemia.
Brennscheidt U; Eick D; Kunzmann R; Martens U; Kiehntopf M; Mertelsmann R; Herrmann F
Leukemia; 1994 May; 8(5):897-902. PubMed ID: 8182948
[TBL] [Abstract][Full Text] [Related]
14. Translocation t(2;8)(p12;q24) in two patients with B Cell chronic lymphocytic leukemia.
Dai HP; Xue YQ; Zhang J; Wu YF; Pan JL; Wang Y; Shen J
Acta Haematol; 2008; 120(4):232-6. PubMed ID: 19246886
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
Caballero D; García-Marco JA; Martino R; Mateos V; Ribera JM; Sarrá J; León A; Sanz G; de la Serna J; Cabrera R; González M; Sierra J; San Miguel J
Clin Cancer Res; 2005 Nov; 11(21):7757-63. PubMed ID: 16278397
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine.
Van Den Neste E; Robin V; Francart J; Hagemeijer A; Stul M; Vandenberghe P; Delannoy A; Sonet A; Deneys V; Costantini S; Ferrant A; Robert A; Michaux L
Leukemia; 2007 Aug; 21(8):1715-22. PubMed ID: 17541398
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
[TBL] [Abstract][Full Text] [Related]
18. Cryptic deletion involving the ATM locus at 11q22.3 approximately q23.1 in B-cell chronic lymphocytic leukemia and related disorders.
Eclache V; Caulet-Maugendre S; Poirel HA; Djemai M; Robert J; Lejeune F; Raphaël M
Cancer Genet Cytogenet; 2004 Jul; 152(1):72-6. PubMed ID: 15193446
[TBL] [Abstract][Full Text] [Related]
19. Burkitt-type acute leukemia in a patient with B-prolymphocytic leukemia: evidence for a common origin.
Nguyen-Khac F; Davi F; Receveur A; Maloum K; Morel V; Le Garff-Tavernier M; Ong J; Berger R; Leblond V; Merle-Béral H
Cancer Genet Cytogenet; 2005 May; 159(1):74-8. PubMed ID: 15860362
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia.
Chow KU; Kim SZ; von Neuhoff N; Schlegelberger B; Stilgenbauer S; Wunderle L; Cordes HJ; Bergmann L
Eur J Haematol; 2011 Nov; 87(5):426-33. PubMed ID: 21749447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
